Create an Account
  1. Home
  2. Meetings
  3. Optometry

Tear Film Homeostasis & the Trigeminal Nerve: An In-Depth Look at the Science Behind Dry Eye

Tear Film Homeostasis the Trigeminal Nerve An InDepth Look at the Science Behind Dry Eye
Media formats available:
Details
Presenters

  • Overview

    Dry eye disease (DED) is a common multifactorial disorder that perpetuates itself in a vicious circle of inflammation, tear film instability, neurosensory abnormalities, and hyperosmolarity resulting in an ongoing immune response.

    This satellite symposium will highlight the latest scientific findings on DED and the novel approaches currently under investigation to treat ocular surface disease.

    This program is not affiliated with the official program of Academy 2021.

    Supported by an unrestricted educational grant from Oyster Point Pharma. 

  • Learning Objectives

    Upon completion of this activity, the participant should be able to:

    • Describe the relationship between nicotinic acetylcholine receptors and the trigeminal nerve
    • Describe the function of the trigeminal nerve/parasympathetic nervous system in tear homeostasis and its dysfunction in dry eye disease (DED)
    • Compare the role of nicotinic receptors as potential future treatments for DED to other potential future treatments for DED

    • Accreditation

      Credit Designation Statement

      Evolve Medical Education LLC (Evolve) is an approved COPE administrator.

      This activity, COPE Activity Number 122690, is accredited by COPE for continuing education for optometrists. 
      This course is approved for 1.5 hours CE. 

      Course #75016-AS
      Activity #122690

    • Participation Method

      In order to obtain credit, proceed through the program, complete the post-test, evaluation and submit for credit.

    • Faculty and Disclosures

      Kelly K. Nichols, OD, MPH, PhD, FAAO

      Kelly K. Nichols, OD, MPH, PhD, FAAO

      Program Chair

      Professor and Dean
      University of Alabama at Birmingham School of Optometry
      Birmingham, AL


      Mile Brujic, OD, FAAO

      Mile Brujic, OD, FAAO

      Partner
      Premier Vision Group
      Bowling Green, OH


      Leslie O’Dell, OD, FAAO

      Leslie O’Dell, OD, FAAO

      Clinical Director
      Medical Optometry America
      York, PA

       


      DISCLOSURE POLICY
      It is the policy of Evolve that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent conflicts of interest relating to the topics of this educational activity. Evolve has full policies in place that will identify and mitigate all conflicts of interest prior to this educational activity.

      The following faculty/staff members have the following financial relationships with commercial interests:

      Kelly K. Nichols, OD, MPH, PhD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Bruder, Dompé, HanAll Bio, Kala Pharmaceuticals, Novartis, Osmotica, Oyster Point Pharma, Sight Sciences, Tarsis, Thea, and Topivent. Grant/Research: Allergan,  Kala Pharmaceuticals, NIH, and Tear Science. Stock/Shareholder: Acquiom, Alcon Vision, LacriScience, and Tear Film Innovations.

      Mile Brujic, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Akorn, Alcon Vision, Allergan, Bausch + Lomb Health, Blephex, Contamac, CSEye, Eyevance, Horizon Therapeutics, Kala Pharmaceuticals, Novartis, Sun Pharmaceutical Industries, VMax Vision, and Zea Vision. Speaker’s Bureau: Allergan, Bausch + Lomb Health, Kala Pharmaceuticals, Novartis, Optovue, Sun Pharmaceutical Industries, and Zea Vision. Grant/Research Support: Contamac.

      Leslie O’Dell, OD, FAAO, has had a financial agreement or affiliation during the past year with the following commercial interests in the form of Consultant: Aerie, Allergan, Bausch + Lomb, Dompe, Eyevance, Johnson & Johnson Vision, Kala Pharmaceuticals, Novartis, Oyster Point, Pharma, Sun Pharmaceutical Industries, Sight Sciences, and Tarsus. Speaker's Bureau: Allergan, Johnson & Johnson Vision, and Sight Sciences.

      The Evolve staff and planners have no financial relationships with commercial interests.

    • Disclaimer

      OFF-LABEL STATEMENT
      This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The opinions expressed in the educational activity are those of the faculty. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

      DISCLAIMER
      The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of Evolve or Oyster Point Pharma.

    • System Requirements

      • Supported Browsers (2 most recent versions):
        • Google Chrome for Windows, Mac OS, iOS, and Android
        • Apple Safari for Mac OS and iOS
        • Mozilla Firefox for Windows, Mac OS, iOS, and Android
        • Microsoft Edge for Windows
      • Recommended Internet Speed: 5Mbps+

    • Publication Dates

      Release Date:

      Expiration Date:

    Ready to Claim Your Credits?

    You have attempts to pass this post-test. Take your time and review carefully before submitting.

    Good luck!

    LIVE ON REACHMD RADIOBack to live radio
    ReachMD Radio

    Loading...

    00:00
    00:00
      Register

      We're glad to see you're enjoying Evolve Medical Education…
      but how about a more personalized experience?

      Register for free